NanoPass

Project: Research

Project Details

Description

nanoPASS aims to showcase a new concept, shifting the testing focus from late in vivo endpoints to early in vitro key events (KEs). We will predict AOs by in silico propagation of the in vitro-observed evolution of early KEs, guided by mechanistic knowledge, in particular adverse outcome pathways (AOPs).
StatusActive
Effective start/end date01/01/202331/12/2026

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.